Cargando…

Limitations of Sulforhodamine 101 for Brain Imaging

Since 2004, the red fluorescent dye Sulforhodamine 101 (SR101) has been boosting the functional analysis of astrocytes in a functional environment in an unprecedented way. However, two major limitations have been challenging the usefulness of this tool for cellular imaging: (i) SR101 is not as speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Hülsmann, Swen, Hagos, Liya, Heuer, Heike, Schnell, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328990/
https://www.ncbi.nlm.nih.gov/pubmed/28293173
http://dx.doi.org/10.3389/fncel.2017.00044
_version_ 1782510969386172416
author Hülsmann, Swen
Hagos, Liya
Heuer, Heike
Schnell, Christian
author_facet Hülsmann, Swen
Hagos, Liya
Heuer, Heike
Schnell, Christian
author_sort Hülsmann, Swen
collection PubMed
description Since 2004, the red fluorescent dye Sulforhodamine 101 (SR101) has been boosting the functional analysis of astrocytes in a functional environment in an unprecedented way. However, two major limitations have been challenging the usefulness of this tool for cellular imaging: (i) SR101 is not as specific for astrocytes as previously reported; and (ii) discoveries of severe excitatory side effects of SR101 are bearing the risk of unwanted alteration of the system of interest. In this article, we summarize the current knowledge about SR101-labeling protocols and discuss the problems that arise from varying of the staining protocols. Furthermore, we provide a testable hypothesis for the observed hyper-excitability that can be observed when using SR101.
format Online
Article
Text
id pubmed-5328990
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53289902017-03-14 Limitations of Sulforhodamine 101 for Brain Imaging Hülsmann, Swen Hagos, Liya Heuer, Heike Schnell, Christian Front Cell Neurosci Neuroscience Since 2004, the red fluorescent dye Sulforhodamine 101 (SR101) has been boosting the functional analysis of astrocytes in a functional environment in an unprecedented way. However, two major limitations have been challenging the usefulness of this tool for cellular imaging: (i) SR101 is not as specific for astrocytes as previously reported; and (ii) discoveries of severe excitatory side effects of SR101 are bearing the risk of unwanted alteration of the system of interest. In this article, we summarize the current knowledge about SR101-labeling protocols and discuss the problems that arise from varying of the staining protocols. Furthermore, we provide a testable hypothesis for the observed hyper-excitability that can be observed when using SR101. Frontiers Media S.A. 2017-02-28 /pmc/articles/PMC5328990/ /pubmed/28293173 http://dx.doi.org/10.3389/fncel.2017.00044 Text en Copyright © 2017 Hülsmann, Hagos, Heuer and Schnell. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Hülsmann, Swen
Hagos, Liya
Heuer, Heike
Schnell, Christian
Limitations of Sulforhodamine 101 for Brain Imaging
title Limitations of Sulforhodamine 101 for Brain Imaging
title_full Limitations of Sulforhodamine 101 for Brain Imaging
title_fullStr Limitations of Sulforhodamine 101 for Brain Imaging
title_full_unstemmed Limitations of Sulforhodamine 101 for Brain Imaging
title_short Limitations of Sulforhodamine 101 for Brain Imaging
title_sort limitations of sulforhodamine 101 for brain imaging
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328990/
https://www.ncbi.nlm.nih.gov/pubmed/28293173
http://dx.doi.org/10.3389/fncel.2017.00044
work_keys_str_mv AT hulsmannswen limitationsofsulforhodamine101forbrainimaging
AT hagosliya limitationsofsulforhodamine101forbrainimaging
AT heuerheike limitationsofsulforhodamine101forbrainimaging
AT schnellchristian limitationsofsulforhodamine101forbrainimaging